Inotuzumab ozogamicin is safe and effective in adult patients with relapsed/refractory B-cell acute lymphoblastic leukaemia, ...

After spending years unsuccessfully attempting to develop a Covid-19 vaccine, Inovio is now reporting promising results from early testing of an experimental Covid treatment.

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

It's early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions ...

The first patient was dosed in a phase 3 trial of IBI354 for platinum-resistant ovarian cancer with HER2 expression.

A method for slowing disease progress in Alzheimer's patients may also delay onset in people predisposed to the disease who ...

Though the drug may have reduced the risk of cognitive ... “We already know from the lecanemab and donanemab data that anti-amyloid antibodies (AAAs) can slow progression of common, sporadic ...

Analysts were happy with batoclimab’s performance in the chronic autoimmune disorder, but Immunovant said it will continue to ...

An experimental drug appears to reduce the risk of Alzheimer ... we have continued treatment with another anti-amyloid antibody in hopes they will never develop symptoms at all.

Findings on golidocitinib for patients with non-small cell lung cancer whose disease has progressed on anti-PD-1 therapy will ...